AI assistant
AstraZeneca PLC — Regulatory Filings 2015
Nov 2, 2015
5229_rns_2015-11-02_2f13bbed-aa49-4438-a0a2-2320d597eb99.html
Regulatory Filings
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 1883E
AstraZeneca PLC
02 November 2015
Transparency Directive
Voting Rights and Capital
The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. On 31 October 2015 the issued share capital of AstraZeneca PLC with voting rights is 1,263,837,596 ordinary shares of US$0.25. No shares are held in Treasury. Therefore, the total number of voting rights in AstraZeneca PLC is 1,263,837,596.
The above figure for the total number of voting rights may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, AstraZeneca PLC under the UK Financial Conduct Authority's Disclosure and Transparency Rules.
A C N Kemp
Company Secretary
2 November 2015
This information is provided by RNS
The company news service from the London Stock Exchange
END
TVRLLFLLLVLFIIE